Company / Shareholders' Equity
Phio Pharmaceuticals Corp. Shareholders' Equity History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.7M
FY2020
5-year range
$1.8M / $13.6M
FY2016-FY2020
Trend
-57.7%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 7 years, ranging from -$6M in FY2013 to $14M in FY2019.
Based on SEC 10-K filings.
$6M in FY2020 with a 3-year CAGR of -19.1%.
Improved from $2M to $6M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -19.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -19.1%, indicating a declining trend.
- In FY2020, shareholders' equity decreased 57.7% year-over-year.
- Peak shareholders' equity was recorded in FY2019.
- Lowest shareholders' equity in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $5.7M | -57.7% |
| FY2019 | $13.6M | +640.8% |
| FY2018 | $1.8M | -83.1% |
| FY2017 | $10.9M | +22.1% |
| FY2016 | $8.9M | +252.2% |
| FY2013 | -$5.8M | -6461.8% |
| FY2012 | -$89.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026